View in EDS PDF Full Text

Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.
Authors: Seidman AD; Memorial Sloan-Kettering Cancer Center, Department of Medicine, Division of Solid Tumor Oncology, New York, NY 10065, USA. seidmana@mskcc.org, Conlin AK, Bach A, Moynahan ME, Lake D, Forero A, Wright GS, Hackney MH, Clawson A, Norton L, Hudis CA
Source: Clinical breast cancer [Clin Breast Cancer] 2013 Aug; Vol. 13 (4), pp. 239-246.e1.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23829890
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Seidman+AD%22">Seidman AD</searchLink>; Memorial Sloan-Kettering Cancer Center, Department of Medicine, Division of Solid Tumor Oncology, New York, NY 10065, USA. seidmana@mskcc.org<br /><searchLink fieldCode="AU" term="%22Conlin+AK%22">Conlin AK</searchLink><br /><searchLink fieldCode="AU" term="%22Bach+A%22">Bach A</searchLink><br /><searchLink fieldCode="AU" term="%22Moynahan+ME%22">Moynahan ME</searchLink><br /><searchLink fieldCode="AU" term="%22Lake+D%22">Lake D</searchLink><br /><searchLink fieldCode="AU" term="%22Forero+A%22">Forero A</searchLink><br /><searchLink fieldCode="AU" term="%22Wright+GS%22">Wright GS</searchLink><br /><searchLink fieldCode="AU" term="%22Hackney+MH%22">Hackney MH</searchLink><br /><searchLink fieldCode="AU" term="%22Clawson+A%22">Clawson A</searchLink><br /><searchLink fieldCode="AU" term="%22Norton+L%22">Norton L</searchLink><br /><searchLink fieldCode="AU" term="%22Hudis+CA%22">Hudis CA</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2013 Aug; Vol. 13 (4), pp. 239-246.e1.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23829890
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clbc.2013.02.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 239
    Titles:
      – TitleFull: Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Seidman AD
      – PersonEntity:
          Name:
            NameFull: Conlin AK
      – PersonEntity:
          Name:
            NameFull: Bach A
      – PersonEntity:
          Name:
            NameFull: Moynahan ME
      – PersonEntity:
          Name:
            NameFull: Lake D
      – PersonEntity:
          Name:
            NameFull: Forero A
      – PersonEntity:
          Name:
            NameFull: Wright GS
      – PersonEntity:
          Name:
            NameFull: Hackney MH
      – PersonEntity:
          Name:
            NameFull: Clawson A
      – PersonEntity:
          Name:
            NameFull: Norton L
      – PersonEntity:
          Name:
            NameFull: Hudis CA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2013 Aug
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0666
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical breast cancer
              Type: main
ResultId 1